When should patients with heterozygous familial hypercholesterolemia be treated?

JAMA

Volumn 281, Issue 2, 1999, Pages 180-181

  Rifkind, B M ^a   Schucker, B ^a   Gordon, D J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEVINOLIN;

CORONARY RISK; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; HETEROZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; ONSET AGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEXUAL MATURATION; TREATMENT PLANNING;

EID: 0033550469     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.2.180     Document Type: Editorial

References (15)